US district court invalidates Megace patent

25-02-2014

US district court invalidates Megace patent

Photo: Gajus / Shutterstock.com

The US District Court for the District of Maryland has ruled that Taiwanese company TWi Pharmaceuticals’ generic version of Par Pharmaceuticals’ Megace ES drug does not infringe US patent 7,101,576.


Par Pharmaceuticals, Megace, TWi Pharmaceuticals, Alkermes, US District Court for the District of Maryland

LSIPR